Prothena | PRTA - Spese Operative

Prezzo Delle Azioni
9.21
Cambio Giornaliero
-0.10 -1.07%
Mensile
2.79%
Annuale
-32.97%
Q1 Previsione
8.93




Spese Operative Cambiamento Data
Acadia Pharmaceuticals USD 266.6M 23.72M 2025-12
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Akebia Therapeutics USD 43.82M 16.98M 2025-03
ALKERMES USD 326.44M 1.41B 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
MacroGenics USD 67M 8M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 577.6M 22M 2025-12
Prothena USD 42.18M 14.25M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Xoma USD 22.84M 1.67M 2024-09